3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Multiple Myeloma
64
Precursor Cell Lymphoblastic Leukemia-Lymphoma
20
Neoplasms, Plasma Cell
14
Recurrence
12
Leukemia
12
Vomiting
11
Lymphoma, Extranodal NK-T-Cell
11
Lymphoma
11
Neoplasms
9
Nausea
6
Lymphoma, Mantle-Cell
6
Lymphoma, Large B-Cell, Diffuse
5
Lymphoma, Non-Hodgkin
4
Lymphoma, Follicular
4
Paraproteinemias
3
Lymphoma, T-Cell, Peripheral
3
Lymphoma, B-Cell, Marginal Zone
3
Lymphohistiocytosis, Hemophagocytic
3
Lung Neoplasms
3
Immunoglobulin Light-chain Amyloidosis
3
Hematologic Diseases
3
Colorectal Neoplasms
3
Carcinoma, Hepatocellular
3
Burkitt Lymphoma
3
Breast Neoplasms
3
Blood Protein Disorders
3
Renal Insufficiency
2
Postoperative Nausea and Vomiting
2
Polycystic Ovary Syndrome
2
Peripheral Nervous System Diseases
2
Interventions
Metformin
2
drospirenone and ethinyl estradiol combination
1
bicalutamide
1
Ultrasonography
1
Topiramate
1
Spironolactone
1
Progesterone
1
Ovidrel
1
Hematologic Tests
1
Ethinyl Estradiol
1
Dexamethasone
1
Cyproterone acetate, ethinyl estradiol drug combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Hyperandrogenism
×
Dexamethasone
×
Clear all
NCT01421810
2023-10-27
CBS001
University of Virginia
Phase NA
Unknown
80 enrolled